Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DXL3DB
|
||||
Drug Name |
rac-3-(4-Nitrophenylamino)-3-phenyl-1-p-tolylpropan-1-one
|
||||
Synonyms |
CHEMBL1163604
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C22H20N2O3
|
||||
Canonical SMILES |
Cc1ccc(cc1)C(=O)CC(Nc2ccc(cc2)[N+](=O)[O-])c3ccccc3
|
||||
InChI |
InChI=1S/C22H20N2O3/c1-16-7-9-18(10-8-16)22(25)15-21(17-5-3-2-4-6-17)23-19-11-13-20(14-12-19)24(26)27/h2-14,21,23H,15H2,1H3
|
||||
InChIKey |
UHIOHBCVVQJMBM-UHFFFAOYSA-N
|
||||
Target and Pathway | |||||
Target(s) | Progesterone receptor | Target Info | [1587926] | ||
mRNA of androgen receptor | Target Info | [1587926] | |||
Pathway Interaction Database | Cellular roles of Anthrax toxinsmad2_3nuclearpathway:Regulation of nuclear SMAD2/3 signaling | ||||
Coregulation of Androgen receptor activity | |||||
Regulation of Androgen receptor activity | |||||
Nongenotropic Androgen signaling | |||||
Regulation of nuclear beta catenin signaling and target gene transcription | |||||
FOXA1 transcription factor network | |||||
Notch-mediated HES/HEY network | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.